MIMOSA Raises Capital, Launches in US

MIMOSA Diagnostics, the Halifax- and Toronto-based maker of a medical device for non-invasively assessing tissue health, has raised an undisclosed funding round as it launches in its beachhead market, the United States.
The raise took the form of a convertible debenture — a hybrid debt and equity financing instrument that gives investors the right to purchase shares later at a predetermined